Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-10 Sale |
2025-03-12 4:00 pm |
Trevi Therapeutics Inc. | TRVI | Simon Farrell Chief Commercial Officer |
81,313 | $6.7502 | $548,878 | 145,237 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-10 Exercise |
2025-03-12 4:00 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | Simon Farrell Chief Commercial Officer |
17,500 | $3.21 | 145,237 (Direct) |
View |
| 2025-03-10 Option Award |
2025-03-12 4:00 pm |
2025-03-10 2034-02-14 |
Trevi Therapeutics Inc. | TRVI | Simon Farrell Chief Commercial Officer |
38,400 | $0 | 145,237 (Direct) |
View |
| 2025-03-10 Exercise |
2025-03-12 4:00 pm |
N/A 2031-02-16 |
Trevi Therapeutics Inc. | TRVI | Simon Farrell Chief Commercial Officer |
112,563 | $0 | 145,237 (Direct) |
View |
| 2025-03-10 Exercise |
2025-03-12 4:00 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | Simon Farrell Chief Commercial Officer |
31,250 | $0.511 | 145,237 (Direct) |
View |
| 2025-03-10 Exercise |
2025-03-12 4:00 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | Simon Farrell Chief Commercial Officer |
63,813 | $3.91 | 145,237 (Direct) |
View |
| 2025-02-18 Option Award |
2025-02-20 4:00 pm |
N/A 2035-02-17 |
Trevi Therapeutics Inc. | TRVI | Simon Farrell Chief Commercial Officer |
225,500 | $0 | 225,500 (Direct) |
View |
| 2024-02-15 Option Award |
2024-02-16 4:43 pm |
N/A 2034-02-14 |
Trevi Therapeutics Inc. | TRVI | Simon Farrell Chief Commercial Officer |
175,000 | $0 | 175,000 (Direct) |
View |
| 2023-06-20 Exercise |
2023-06-21 4:00 pm |
N/A 2032-02-10 |
Trevi Therapeutics Inc. | TRVI | Simon Farrell Chief Commercial Officer |
6,250 | $0 | 95,650 (Direct) |
View |
| 2023-06-20 Exercise |
2023-06-21 4:00 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | Simon Farrell Chief Commercial Officer |
6,250 | $0.511 | 95,650 (Direct) |
View |
| 2023-03-07 Exercise |
2023-03-08 4:00 pm |
N/A 2032-02-10 |
Trevi Therapeutics Inc. | TRVI | Simon Farrell Chief Commercial Officer |
18,750 | $0 | 95,650 (Direct) |
View |
| 2023-03-07 Exercise |
2023-03-08 4:00 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | Simon Farrell Chief Commercial Officer |
18,750 | $0.511 | 95,650 (Direct) |
View |
| 2023-02-16 Option Award |
2023-02-16 5:30 pm |
N/A 2033-02-15 |
Trevi Therapeutics Inc. | TRVI | Simon Farrell Chief Commercial Officer |
100,000 | $0 | 100,000 (Direct) |
View |
Ownership |
2023-02-16 5:26 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | Simon Farrell Chief Commercial Officer |
0 | $0 | 188,150 (Direct) |
View |